glp-1 for ckd and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 Receptor Agonists and Kidney
Description
Yadav, H., Lee, J
Int J Mol Med 2017;39:102936.ArticlePubMed 57
Most employers that are cutting GLP-1 coverage are specifically cutting coverage for weight management indications meaning Wegovy, Zepbound, and Saxenda prescribed for obesity
doi: 10.1016/j.trsl.2022.03.008
